MLAB:NGS-Mesa Laboratories Inc. (USD)

EQUITY | Scientific & Technical Instruments | Nasdaq Global Select

Last Closing

USD 118.84

Change

0.00 (0.00)%

Market Cap

USD 0.50B

Volume

0.04M

Analyst Target

USD 271.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Mesa Laboratories Inc designs, manufactures and markets quality control instruments and disposable products and also manufactures and markets biological indicators and distributes chemical indicators.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-10 )

Largest Industry Peers for Scientific & Technical Instruments

Symbol Name Price(Change) Market Cap
TRMB Trimble Inc

-0.55 (-0.75%)

USD 14.95B
CGNX Cognex Corporation

-0.67 (-1.56%)

USD 6.93B
MKSI MKS Instruments Inc

-1.26 (-1.10%)

USD 6.77B
NOVT Novanta Inc

-4.05 (-2.27%)

USD 6.26B
ITRI Itron Inc

-3.22 (-2.59%)

USD 5.04B
ITRN Ituran Location and Control Lt..

-0.07 (-0.25%)

USD 0.53B
FARO FARO Technologies Inc

-0.35 (-1.25%)

USD 0.34B
MVIS Microvision Inc

-0.10 (-9.17%)

USD 0.23B
SOTK Sono-Tek Corp

+0.04 (+0.93%)

USD 0.07B
LUNA Luna Innovations Incorporated

-0.02 (-1.24%)

USD 0.06B

ETFs Containing MLAB

N/A

Market Performance

  Market Performance vs. Industry/Classification (Scientific & Technical Instruments) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.43% 77% C+ 67% D+
Dividend Return 0.46% 25% F 8% B-
Total Return 13.89% 77% C+ 65% D
Trailing 12 Months  
Capital Gain 39.75% 73% C 74% C
Dividend Return 0.75% 25% F 8% B-
Total Return 40.50% 73% C 73% C
Trailing 5 Years  
Capital Gain -48.95% 35% F 26% F
Dividend Return 1.37% 25% F 4% F
Total Return -47.58% 35% F 25% F
Average Annual (5 Year Horizon)  
Capital Gain -14.64% 18% F 16% F
Dividend Return -14.35% 18% F 16% F
Total Return 0.29% 25% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 24.87% 100% F 70% C-
Risk Adjusted Return -57.72% 18% F 12% F
Market Capitalization 0.50B 74% C 64% D

Key Financial Ratios

  Ratio vs. Industry/Classification (Scientific & Technical Instruments) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 44.80 15% 1%
Price/Book Ratio 4.09 32% 28%
Price / Cash Flow Ratio 13.98 47% 22%
Price/Free Cash Flow Ratio 305.65 5% 1%
Management Effectiveness  
Return on Equity -92.97% 33% 21%
Return on Invested Capital 5.23% 71% 67%
Return on Assets 1.24% 62% 69%
Debt to Equity Ratio 152.48% 25% 15%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.